Y. Guan

发表

polycythemia Mutations in the VHL gene in sporadic apparently congenital

J. Jelinek, J. Prchal, L. Krishnamurti, 2013 .

Mutations in the VHL gene in sporadic apparently congenital polycythemia.

J. Jelinek, J. Prchal, L. Krishnamurti, 2003, Blood.

Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin.

J. Jelinek, J. Prchal, J. Prchal, 2003, Blood.

Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera.

R. Kralovics, J. Prchal, Y. Guan, 2002, Experimental hematology.

Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients.

R. Gatti, J. Prchal, Ko-Tung Chang, 2005, Haematologica.

Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.

G. Semenza, J. Prchal, L. Sokol, 1995, Blood.

High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension.

A. Frost, J. Prchal, U. Popat, 2006, Blood.

Heterogeneity of the molecular biology of methemoglobinemia: a study of eight consecutive patients.

J. Prchal, C. Ou, Y. Guan, 2004, Haematologica.

A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions

A. Bernardo, N. Jing, José A López, 2009, Thrombosis and Haemostasis.

Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia

David Mole, Kiichi Hirota, Enli Liu, 2002, Nature Genetics.

Potassium-dependent folding: a key to intracellular delivery of G-quartet oligonucleotides as HIV inhibitors.

N. Jing, Shimei Wang, Y. Guan, 2002, Biochemistry.

Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.

J. Prchal, H. Hasle, J. Fahner, 2003, American journal of human genetics.

The worldwide distribution of the VHL 598C>T mutation indicates a single founding event.

S. Shete, C. Amos, D. Stockton, 2004, Blood.

A perylene derivative regulates HIF-1α and Stat3 signaling pathways.

N. Jing, G. Yuan, Y. Guan, 2014, Bioorganic & medicinal chemistry.

Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.

J. Prchal, D. Pospíšilová, K. Indrák, 2005, Blood.

Combined treatment targeting HIF‐1α and Stat3 is a potent strategy for prostate cancer therapy

N. Jing, Zhou Zhou, Y. Guan, 2011, The Prostate.

G-rich Oligonucleotides Inhibit HIF-1α and HIF-2α and Block Tumor Growth.

G. Semenza, N. Jing, J. Prchal, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signaling

N. Jing, D. Tweardy, Ruiwen Zhang, 2008, The Prostate.

In Vitro Expansion of Polycythemia Vera Progenitors Favors Expansion of Erythroid Precursors without JAK2 V617F Mutation.

J. Issa, J. Jelinek, J. Prchal, 2005 .

Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism

M. Cooper, J. Prchal, M. Belickova, 1996, The Journal of experimental medicine.